U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula IO3
Molecular Weight 174.9027
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge -1

SHOW SMILES / InChI
Structure of IODATE ION

SMILES

[O-]I(=O)=O

InChI

InChIKey=ICIWUVCWSCSTAQ-UHFFFAOYSA-M
InChI=1S/HIO3/c2-1(3)4/h(H,2,3,4)/p-1

HIDE SMILES / InChI

Molecular Formula HIO3
Molecular Weight 175.9106
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

The iodate ion is an oxoanion of iodine bearing a negative charge and containing three oxygen atoms. Because it is more stable than iodide, most health authorities preferentially recommend iodate as an additive to salt for correcting iodine deficiency. In humans and rats, oral bioavailability of iodine from iodate is virtually equivalent to that from iodide. When given intravenously to rats, or when added to whole blood or tissue homogenates in vitro or to foodstuff, iodate is quantitatively reduced to iodide by nonenzymatic reactions, and thus becomes available to the body as iodide. Therefore, except perhaps for the gastrointestinal mucosa, exposure of tissues to iodate might be minimal. At much higher doses given intravenously (i.e., above 10 mg/kg), iodate is highly toxic to the retina. Ocular toxicity in humans has occurred only after exposure to doses of 600 to 1,200 mg per individual. Oral exposures of several animal species to high doses, exceeding the human intake from fortified salt by orders of magnitude, pointed to corrosive effects in the gastrointestinal tract, hemolysis, nephrotoxicity, and hepatic injury.

Approval Year

PubMed

PubMed

TitleDatePubMed
Diagnosis and management of lymphoceles after renal transplantation.
1988 Apr
[Current problems in the pathogenesis and treatment of endemic goiter].
1990
The inactivation of sodium channels in the node of Ranvier and its chemical modification.
1990
[A volumetric increase in the submandibular glands due to an organic iodate contrast medium. A case report].
1993 Jan-Feb
Regeneration of mammalian retinal pigment epithelium.
1994
Iodine deficiency disorders in South Africa.
1998 Mar
[The possibilities of using the newest experimental results in the progressive myopia treatment].
1999
The toxicology of iodate: a review of the literature.
2001 May
Iodised salt for preventing iodine deficiency disorders.
2002
Ozonation of drinking water: part II. Disinfection and by-product formation in presence of bromide, iodide or chlorine.
2003 Apr
Iodine supplementation for preventing iodine deficiency disorders in children.
2004
Exploiting genotypic variation in plant nutrient accumulation to alleviate micronutrient deficiency in populations.
2005
Fifty-five-year personal experience with human nutrition worldwide.
2007
Patents

Patents

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:49:18 GMT 2023
Edited
by admin
on Fri Dec 15 16:49:18 GMT 2023
Record UNII
877S7T6EXV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IODATE ION
Common Name English
IODATE (IO3(1-))
Common Name English
Code System Code Type Description
CAS
15454-31-6
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY
SMS_ID
300000031655
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY
EPA CompTox
DTXSID90165657
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY
RXCUI
1546442
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY RxNorm
PUBCHEM
84927
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY
FDA UNII
877S7T6EXV
Created by admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY